SCHEMBL22406829

SCHEMBL22406829

COC(=O)C(=O)c1ccc(Oc2ccc(C(F)(F)F)cc2)cc1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP11B1 P15538 2/20 0.44
▸ CYP11B2 P19099 2/20 0.44
▸ GSTP1 P09211 1/20 0.43
▸ CFTR P13569 1/20 0.42
▸ TLR7 Q9NYK1 2/20 0.41
▸ LMNA P02545 1/20 0.41
▸ GPR35 Q9HC97 1/20 0.41
▸ TLR8 Q9NR97 3/20 0.41
▸ HTR2A P28223 2/20 0.40
▸ SLC6A4 P31645 2/20 0.40
▸ KCNH2 Q12809 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ ATM Q13315 1/20 0.40
▸ PPARG P37231 1/20 0.40
▸ PPARD Q03181 1/20 0.40
▸ PPARA Q07869 1/20 0.40
▸ JAK2 O60674 1/20 0.40
▸ TYK2 P29597 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22406805 0.88 AKR1C3 (0.42) LMNAKDM4EMAPTKMT2AJAK2
SCHEMBL22406872 0.87 SCN9A (0.43) PPARA
SCHEMBL28391562 0.85 CES2 (0.53) CFTRLMNATLR8KDM4EMAPT
SCHEMBL22407007 0.85 PPARA (0.43) GSTP1PPARGPPARDPPARAJAK2
SCHEMBL22439736 0.85 MEN1 (0.46) CYP11B1CYP11B2GSTP1TLR7TLR8
SCHEMBL22407053 0.85 MAPT (0.49) LMNAKCNH2MAPTKMT2AJAK2
SCHEMBL22406946 0.85 FLT1 (0.48) CYP11B1CYP11B2KCNH2MAPTATM
SCHEMBL29380080 0.85 FLT1 (0.48) CYP11B1CYP11B2KCNH2MAPTATM
SCHEMBL28388084 0.84 GSTP1 (0.43) GSTP1CFTRTLR7LMNATLR8
SCHEMBL22407104 0.83 TLR8 (0.44) CYP11B1CYP11B2GSTP1TLR7TLR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3712135-B1 AZOLE DERIVATIVE, INTERMEDIATE COMPOUND, METHOD FOR PRODUCING AZOLE DERIVATIVE, AGENT FOR AGRICULTURAL AND HORTICULTURAL USE, AND MATERIAL PROTECTION AGENT FOR INDUSTRIAL USE KUREHA CORP (JP) 2023-05-03 — — EP disclosed
CN-111032631-B Azole derivative, intermediate compound, process for producing azole derivative, agricultural and horticultural chemical, and industrial material protective agent 株式会社吴羽 2021-05-07 — — CN disclosed
US-10945434-B2 Azole derivative, intermediate compound, method for producing azole derivative, agricultural or horticultural chemical agent, and protective agent for industrial material KUREHA CORPORATION (JP) 2021-03-16 — — US disclosed
US-20200288714-A1 AZOLE DERIVATIVE, INTERMEDIATE COMPOUND, METHOD FOR PRODUCING AZOLE DERIVATIVE, AGRICULTURAL OR HORTICULTURAL CHEMICAL AGENT, AND PROTECTIVE AGENT FOR INDUSTRIAL MATERIAL KUREHA CORPORATION (JP) 2020-09-17 — — US disclosed
CN-111032631-A Azole derivative, intermediate compound, process for producing azole derivative, agricultural and horticultural chemical, and industrial material protective agent 株式会社吴羽 2020-04-17 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10945434-B2 Azole derivative, intermediate compound, method for producing azole derivative, agricultural or horticultural chemical agent, and protective agent for industrial material NOS2, NOS1, CYP51A1 CYP11B1 24/4885CYP11B2 27/4885GSTP1 656/4885
US-20200288714-A1 AZOLE DERIVATIVE, INTERMEDIATE COMPOUND, METHOD FOR PRODUCING AZOLE DERIVATIVE, AGRICULTURAL OR HORTICULTURAL CHEMICAL AGENT, AND PROTECTIVE AGENT FOR INDUSTRIAL MATERIAL NOS2, NOS1, CYP51A1 CYP11B1 24/4885CYP11B2 27/4885GSTP1 656/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback